Senators Reject White House Proposal for NIH Overhead Cost Cap
Key Republican senators, including Appropriations Committee Chair Susan Collins and Subcommittee Chair Shelley Moore Capito, have rejected the White House's renewed proposal to cap indirect costs for National Institutes of Health (NIH) research grants at 15 percent. The administration argues this cap would increase transparency, but lawmakers contend it is a one-size-fits-all approach that could hinder medical research. Instead, they are considering the FAIR (Financial Accountability In Research) model, which aims to enhance accountability without imposing a uniform percentage limit. This legislative pushback follows previous congressional rejection of similar measures in the fiscal 2026 cycle and a successful legal challenge where federal courts issued a permanent injunction against the NIH's attempt to enforce the cap. Senators emphasize the need to support research institutions while ensuring responsible financial oversight. The debate highlights the ongoing tension between federal budget constraints and the operational realities of major research universities, where indirect costs typically range from 30 to 70 percent of total grants. As lawmakers prepare for fiscal 2027 spending bills, consensus remains elusive on the best alternative to the proposed cap.
Wire timeline
Senators Reject White House Proposal for NIH Overhead Cost Cap
Key Republican senators, including Appropriations Committee Chair Susan Collins and Subcommittee Chair Shelley Moore Capito, have rejected the White House's renewed proposal to cap indirect costs for National Institutes of Health (NIH) research grants at 15 percent. The administration argues this cap would increase transparency, but lawmakers contend it is a one-size-fits-all approach that could hinder medical research. Instead, they are considering the FAIR (Financial Accountability In Research) model, which aims to enhance accountability without imposing a uniform percentage limit. This legislative pushback follows previous congressional rejection of similar measures in the fiscal 2026 cycle and a successful legal challenge where federal courts issued a permanent injunction against the NIH's attempt to enforce the cap. Senators emphasize the need to support research institutions while ensuring responsible financial oversight. The debate highlights the ongoing tension between federal budget constraints and the operational realities of major research universities, where indirect costs typically range from 30 to 70 percent of total grants. As lawmakers prepare for fiscal 2027 spending bills, consensus remains elusive on the best alternative to the proposed cap.
Roll Call